GB Virus Type C: A Virus in Search of a Disease or a Role in HIV Therapy?

Bollinger, Robert C.; Gupta, Amita
February 2004
Clinical Infectious Diseases;2/1/2004, Vol. 38 Issue 3, p410
Academic Journal
Focuses on the impact of Guillain-Barre virus C (GBV-C), a single-stranded RNA flavivirus, on the course of HIV treatment in Africa. Transmission of the virus through sexual exposure; Inverse correlation demonstrated between GBV-C load and HIV-1 load in coinfected individuals; Data on the prevalence of GBV-C coinfection in any HIV- infected population in the country; Analyses of infants born to a subset of several HIV- infected South African mothers.


Related Articles

  • Meningoencefalite e Síndroma de Miller Fisher em seroconversão VIH1 -- caso clínico. Caetano, Sofia; Ramos, Isabel; Sá, Rosa; Santana, Isabel; da Cunha, Saraiva; Meliço-Silvestre, A. // RPDI - Revista Portuguesa de Doenças Infecciosas;jan-abr2009, Vol. 5 Issue 1, p37 

    The clinical presentations associated to acute HIV type 1 infection can be very pleomorphi; mononucleosic syndrome is the most common presentation, but neurological features can be present on 17% of cases. Linphocytic meningitis, encephalitis, Guillain-Barré syndrome syndrome and variants...

  • Guillain-Barré Syndrome Associated with Immune Reconstitution. Piliero, Peter J.; Fish, Douglas G.; Preston, Sandra; Cunningham, Donna; Kinchelow, Tosca; Salgo, Miklos; Qian, Jiang; Drusano, George L. // Clinical Infectious Diseases;5/1/2003, Vol. 36 Issue 9, pe111 

    We report a case of acute Guillain-Barré syndrome (GBS) associated with a prompt and vigorous immune reconstitution and decrease in the virus load noted during treatment with a potent regimen of highly active antiretroviral therapy. We hypothesize that GBS may have been due to an aberrant...

  • A Role for Interferon-β in Guillain-Barré Syndrome? Créange, A. // BioDrugs;2000, Vol. 14 Issue 1, p1 

    Guillain-Barré syndrome (GBS) is an acute inflammatory demyelinating neuropathy that is associated with long-lasting morbidity and a substantial risk of mortality. The 2 reference treatments, plasma exchange and intravenous immunoglobulins (IVIg), do not change the functional prognosis for...

  • Expanding the concept of inflammatory neuropathies. Koike, Haruki; Sobue, Gen // Brain: A Journal of Neurology;Oct2010, Vol. 133 Issue 10, p2848 

    This article discusses several research papers on inflammatory neuropathies. These neuropathies include Guillain-Barré syndrome and chronic inflammatory demyelinating polyneuropathy. A study was by Staff et al. focusing on patients who developed peripheral neuropathy within 30 days of a...

  • Rituximab.  // Reactions Weekly;6/5/2010, Issue 1304, p31 

    The article describes the case of an 86-year-old male patient who suffered from Guillain-Barré syndrome while taking rituximab for idiopathic thrombocytopenic purpura.

  • Ten-Year Prospective Study (Clinical Spectrum) of Childhood Guillain-Barré Syndrome in the Arabian Peninsula: Comparison of Outcome in Patients in the Pre- and Post-Intravenous Immunoglobulin Eras. Koul, Roshan; Chacko, Alexander; Ahmed, Riaz; Varghese, Thomas; Javed, Hashim; Al-Lamki, Zakia // Journal of Child Neurology;Nov2003, Vol. 18 Issue 11, p767 

    A prospective study of Guillain-Barré syndrome from January 1992 to December 2001 was undertaken. Intravenous immunoglobulins were used in all patients. All patients were followed up until complete recovery. Various parameters, such as onset of weakness, duration of hospital stay, ventilation...

  • Alemtuzumab.  // Reactions Weekly;7/31/2010, Issue 1312, p8 

    The article describes the case of a 73-year-old man with T-cell prolymphocytic leukaemia who developed Guillain-Barré syndrome (GBS) after taking alemtuzumab and eventually underwent plasmapheresis.

  • Ciclosporin/tacrolimus.  // Reactions Weekly;1/19/2013, Issue 1435, p10 

    The article describes the case of a 68-year-old man who developed Guillain-Barre syndrome (GBS) while receiving tacrolimus and ciclosporin.

  • Influenza A virus vaccine-H1N1.  // Reactions Weekly;3/12/2011, Issue 1342, p19 

    The article describes the case of two men who acquired Guillain-Barre syndrome following administration of the influenza A virus vaccine-H1N1.


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics